Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...
Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...
Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular ...
Insilico Medicine (“Insilico”), a world-leading artificial intelligence (AI)-driven drug discovery company, today announced a ...
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...
Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular senescence ...
Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...
Harbour BioMed inks long-term strategic collaboration with Lannacheng to advance next-generation radionuclide drug conjugates: Shanghai, China Tuesday, December 30, 2025, 13:00 Hr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback